SPECT Imaging with Tc-99m-Labeled HYNIC-FAPI-04 to Extend the Differential Time Window in Evaluating Tumor Fibrosis
暂无分享,去创建一个
Zhe Zhang | Tao Wang | Chao Cheng | Xiao Li | Changjing Zuo | G. Yuan | Rou Li | Zhe Zhang | Xiao Li | Xiu Luo | Danzhou Fang | Rou Li
[1] Ming-Rong Zhang,et al. Highlight selection of radiochemistry and radiopharmacy developments by editorial board , 2022, EJNMMI Radiopharmacy and Chemistry.
[2] Zeyu Zhang,et al. Comparison of the diagnostic efficacy of 68 Ga-FAPI-04 PET/MR and 18F-FDG PET/CT in patients with pancreatic cancer , 2022, European Journal of Nuclear Medicine and Molecular Imaging.
[3] Xuran Zhang,et al. Preparation and Bioevaluation of 99mTc-Labeled FAP Inhibitors as Tumor Radiotracers to Target the Fibroblast Activation Protein. , 2021, Molecular pharmaceutics.
[4] B. Kilbas,et al. Fully-automated synthesis of 177Lu labelled FAPI derivatives on the module modular lab-Eazy , 2021, EJNMMI Radiopharmacy and Chemistry.
[5] S. Falco,et al. The use of 68Ga prostate-specific membrane antigen PET-CT in prostate cancer: diagnostic challenges and therapeutic opportunities , 2021, Future science OA.
[6] Nan Li,et al. Clinical translational evaluation of Al18F-NOTA-FAPI for fibroblast activation protein-targeted tumour imaging , 2021, European Journal of Nuclear Medicine and Molecular Imaging.
[7] R. Tothill,et al. FAPI PET/CT: Will It End the Hegemony of 18F-FDG in Oncology? , 2020, The Journal of Nuclear Medicine.
[8] Haitao Zhao,et al. Comparison of PET imaging of activated fibroblasts and 18F-FDG for diagnosis of primary hepatic tumours: a prospective pilot study , 2020, European Journal of Nuclear Medicine and Molecular Imaging.
[9] L. Terracciano,et al. High Expression of FAP in Colorectal Cancer Is Associated With Angiogenesis and Immunoregulation Processes , 2020, Frontiers in Oncology.
[10] Hua Wu,et al. Usefulness of [68Ga]Ga-DOTA-FAPI-04 PET/CT in patients presenting with inconclusive [18F]FDG PET/CT findings , 2020, European Journal of Nuclear Medicine and Molecular Imaging.
[11] Hua Wu,et al. Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer , 2020, European Journal of Nuclear Medicine and Molecular Imaging.
[12] J. Konvalinka,et al. Molecular recognition of fibroblast activation protein for diagnostic and therapeutic applications. , 2020, Biochimica et biophysica acta. Proteins and proteomics.
[13] Shaoli Song,et al. Evaluation of Radiation dosimetry of 99mTc-HYNIC-PSMA and imaging in prostate cancer , 2020, Scientific Reports.
[14] T. Watabe,et al. Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: 64Cu- and 225Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models , 2019, The Journal of Nuclear Medicine.
[15] Fariborz Bagheri,et al. Direct comparison of 99mTc-PSMA SPECT/CT and 68Ga-PSMA PET/CT in patients with prostate cancer , 2020, Asia Oceania journal of nuclear medicine & biology.
[16] J. Giglio,et al. 99mTc Labelling Strategies for the Development of Potential Nitroimidazolic Hypoxia Imaging Agents , 2019, Inorganics.
[17] Thomas Lindner,et al. Development of Fibroblast Activation Protein–Targeted Radiotracers with Improved Tumor Retention , 2019, The Journal of Nuclear Medicine.
[18] Frederik L. Giesel,et al. 68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer , 2019, The Journal of Nuclear Medicine.
[19] D. Jäger,et al. A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts , 2018, The Journal of Nuclear Medicine.
[20] Thomas Lindner,et al. Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein , 2018, The Journal of Nuclear Medicine.
[21] D. McMillan,et al. The Relationship Between Tumor Glucose Metabolism and Host Systemic Inflammatory Responses in Patients with Cancer: A Systematic Review , 2018, The Journal of Nuclear Medicine.
[22] Frederik L. Giesel,et al. 68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers , 2018, The Journal of Nuclear Medicine.
[23] K. Pienta,et al. Targeting the tumour stroma to improve cancer therapy , 2018, Nature Reviews Clinical Oncology.
[24] S. Hosseinimehr,et al. 99mTc-HYNIC-(tricine/EDDA)-FROP peptide for MCF-7 breast tumor targeting and imaging , 2018, Journal of Biomedical Science.
[25] Jun Zhou 周 俊,et al. Diagnosis performance of 99mTc-MIBI and multimodality imaging for hyperparathyroidism , 2017, Journal of Huazhong University of Science and Technology [Medical Sciences].
[26] B. Bettencourt,et al. Serial scanning with technetium pyrophosphate (99mTc-PYP) in advanced ATTR cardiac amyloidosis , 2016, Journal of Nuclear Cardiology.
[27] O. Schilling,et al. Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapy , 2014, Proteomics. Clinical applications.
[28] S. Bae,et al. Incidental abnormal FDG uptake in the prostate on 18-fluoro-2-deoxyglucose positron emission tomography-computed tomography scans. , 2014, Asian Pacific journal of cancer prevention : APJCP.
[29] R. Palmqvist,et al. High intratumoral expression of fibroblast activation protein (FAP) in colon cancer is associated with poorer patient prognosis , 2013, Tumor Biology.
[30] J. Capala,et al. The role of nuclear medicine in modern therapy of cancer , 2012, Tumor Biology.
[31] R. Najafi,et al. Clinical evaluation of antimicrobial peptide [(99m)Tc/Tricine/HYNIC(0)]ubiquicidin 29-41 as a human-specific infection imaging agent. , 2009, Nuclear medicine and biology.
[32] Harvey A. Ziessman,et al. Comparison of SPECT/CT, SPECT, and Planar Imaging with Single- and Dual-Phase 99mTc-Sestamibi Parathyroid Scintigraphy , 2007, Journal of Nuclear Medicine.
[33] Raghu Kalluri,et al. Fibroblasts in cancer , 2006, Nature Reviews Cancer.
[34] M. Saurer,et al. 99mTc-labeling and in vitro and in vivo evaluation of HYNIC- and (Nalpha-His)acetic acid-modified [D-Glu1]-minigastrin. , 2004, Bioconjugate chemistry.
[35] Janet F Eary,et al. Nuclear medicine in cancer diagnosis , 1999, The Lancet.
[36] J. Healey,et al. Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. , 1994, Proceedings of the National Academy of Sciences of the United States of America.